These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1858560)

  • 21. Association of low-density lipoprotein particle size and ratio of different lipoproteins and apolipoproteins with coronary heart disease.
    Biswas S; Ghoshal PK; Mandal SC; Mandal N
    J Cardiol; 2008 Oct; 52(2):118-26. PubMed ID: 18922385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High apolipoprotein B with low high-density lipoprotein cholesterol and normal plasma triglycerides and cholesterol.
    Sniderman AD; Dagenais GR; Cantin B; Després JP; Lamarche B
    Am J Cardiol; 2001 Mar; 87(6):792-3, A8. PubMed ID: 11249908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.
    Dashti N; Alaupovic P; Knight-Gibson C; Koren E
    Biochemistry; 1987 Jul; 26(15):4837-46. PubMed ID: 2822101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in the levels and composition of lipoproteins and apolipoproteins of blood plasma in patients with ischemic heart disease after hemosorption].
    Torkhovskaia TI; Khalilov EM; Oleĭnik IA; Kliuchnikova ZhI; Klimov AN
    Kardiologiia; 1989 Oct; 29(10):60-4. PubMed ID: 2615161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.
    Frost PH; Havel RJ
    Am J Cardiol; 1998 Feb; 81(4A):26B-31B. PubMed ID: 9526810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between bilirubin, apolipoprotein B, and coronary artery disease.
    Levinson SS
    Ann Clin Lab Sci; 1997; 27(3):185-92. PubMed ID: 9142370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma lipids-lipoproteins in coronary artery disease. Regulation and control.
    Kuo PT
    Chest; 1980 Nov; 78(5):679-81. PubMed ID: 7428450
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cholesterol, lipoproteins and risk factors in atherosclerosis].
    Fruchart JC
    Rev Prat; 1986 Jan; 36(3):93-8. PubMed ID: 3945785
    [No Abstract]   [Full Text] [Related]  

  • 29. [Apolipoprotein A-I and B in laboratory diagnostics of dyslipidemia--what benefits do we gain compared with cholesterol measurements?].
    Leiviskä J; Sundvall J; Jauhiainen M; Laatikainen T
    Duodecim; 2014; 130(22-23):2331-7. PubMed ID: 25558595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical significance of remnant-lipoprotein].
    Nakamura Y; Miida T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():22-5. PubMed ID: 15658253
    [No Abstract]   [Full Text] [Related]  

  • 31. The lipid and lipoprotein profiles of apo B-carrying particles in remnant-like lipoproteins isolated from plasma in sudden cardiac death cases.
    Nakajima Y; Takeichi S; Osawa M; Nakajima K; Nakano T; Fujita MQ
    Tokai J Exp Clin Med; 2006 Dec; 31(4):160-6. PubMed ID: 21302248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherogenicity of blood serum from patients with coronary heart disease.
    Chazov EI; Tertov VV; Orekhov AN; Lyakishev AA; Perova NV; Kurdanov KA; Khashimov KA; Novikov ID; Smirnov VN
    Lancet; 1986 Sep; 2(8507):595-8. PubMed ID: 2875319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.
    Wallenfeldt K; Bokemark L; Wikstrand J; Hulthe J; Fagerberg B
    Stroke; 2004 Oct; 35(10):2248-52. PubMed ID: 15345795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus.
    Duvillard L; Pont F; Florentin E; Gambert P; Vergès B
    Diabetologia; 2000 Jan; 43(1):27-35. PubMed ID: 10663213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Plasma exchange therapy in a patient with familial hypercholesteremia and generalized arteriosclerosis].
    Schrecker O; Thies K; Schlierf G
    Internist (Berl); 1984 Sep; 25(9):574-6. PubMed ID: 6386739
    [No Abstract]   [Full Text] [Related]  

  • 37. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
    Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
    Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein B and apolipoprotein AI as predictors of coronary artery disease.
    Sniderman AD
    Can J Cardiol; 1988 Jul; 4 Suppl A():24A-30A. PubMed ID: 3141025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure.
    Kimak E; Solski J
    Ren Fail; 2002 Jul; 24(4):485-92. PubMed ID: 12212828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weighing in before the fight: low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy.
    Denke MA
    Circulation; 2005 Nov; 112(22):3368-70. PubMed ID: 16316961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.